Bio-Rad Laboratories Inc [NYSE: BIO] traded at a high on Wednesday, posting a 0.22 gain after which it closed the day’ session at $338.48.
The results of the trading session contributed to over 127564 shares changing hands. Over the past one week, the price volatility of Bio-Rad Laboratories Inc stands at 3.12% while the volatility over the past one month is 3.65%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for BIO stock reached $9.47 billion, with 23.42 million shares outstanding and 19.15 million shares in the current float. Compared to the average trading volume of 295.96K shares, BIO reached a trading volume of 127564 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Bio-Rad Laboratories Inc [BIO]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BIO shares is $397.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BIO stock is a recommendation set at 1.86. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Bio-Rad Laboratories Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 01, 2024. While these analysts kept the previous recommendation, Wells Fargo raised their target price to Equal Weight. The new note on the price target was released on August 28, 2024, representing the official price target for Bio-Rad Laboratories Inc stock. Previously, the target price had yet another raise to $315, while Jefferies analysts kept a Hold rating on BIO stock. On April 03, 2024, analysts decreased their price target for BIO shares from 400 to 365.
The Average True Range (ATR) for Bio-Rad Laboratories Inc is set at 11.75, with the Price to Sales ratio for BIO stock in the period of the last 12 months amounting to 3.67. The Price to Book ratio for the last quarter was 1.27, with the Price to Cash per share for the same quarter was set at 58.25. Price to Free Cash Flow for BIO in the course of the last twelve months was 38.40 with Quick ratio for the last quarter at 4.52.
How has BIO stock performed recently?
Bio-Rad Laboratories Inc [BIO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.57. With this latest performance, BIO shares gained by 2.06% in over the last four-week period, additionally plugging by 20.02% over the last 6 months – not to mention a rise of 11.20% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BIO stock in for the last two-week period is set at 48.57, with the RSI for the last a single of trading hit 49.19, and the three-weeks RSI is set at 49.29 for Bio-Rad Laboratories Inc [BIO]. The present Moving Average for the last 50 days of trading for this stock 340.63, while it was recorded at 334.16 for the last single week of trading, and 317.51 for the last 200 days.
Bio-Rad Laboratories Inc [BIO]: Deeper insight into the fundamentals
Bio-Rad Laboratories Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.52 and a Current Ratio set at 6.14.
Earnings analysis for Bio-Rad Laboratories Inc [BIO]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BIO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Bio-Rad Laboratories Inc go to 12.00%.
Insider trade positions for Bio-Rad Laboratories Inc [BIO]
There are presently around $79.95%, or 94.70%% of BIO stock, in the hands of institutional investors. The top three institutional holders of BIO stocks are: VANGUARD GROUP INC with ownership of 2.37 million shares, which is approximately 8.3263%. BLACKROCK INC., holding 1.55 million shares of the stock with an approximate value of $$423.48 million in BIO stocks shares; and BLACKROCK INC., currently with $$308.29 million in BIO stock with ownership which is approximately 3.9582%.
